Medicine
Phexx 50 mg/90 mg/20 mg per 5 g vaginal gel
Phexx 50 mg/90 mg/20 mg per 5 g vaginal gel is a prescription medicine containing Citric acid, Lactic acid, l- and Potassium bitartrate for vaginal use, marketed by Evofem, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in the original foil pack at room temperature 20°C to 25°C (68°F to…
Key facts
- Active ingredient (INN)
- Citric acid, Lactic acid, l- and Potassium bitartrate
- Brand
- Phexx
- Strength
- 50 mg/90 mg/20 mg per 5 g
- Dosage form
- Vaginal gel
- Route
- Vaginal
- Packs
- 12 applicators
- Marketing authorisation holder
- Evofem
- Manufacturer
- Evofem
- Origin register
- US FDA, United States
- Storage
- Store in the original foil pack at room temperature 20°C to 25°C (68°F to 77°F), excursion permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 August 2020
- Identifiers
- RxCUI 2385348, 2700386DailyMed set ID 14b01a15-9b47-4be3-bb2e-a2010eab429eNDC 69751-101Application NDA208352
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 applicator in 1 box / 5 g in 1 applicator | 69751-101-12 | Evofem | 1 September 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Citric acid, Lactic acid, l- and Potassium bitartrate 50 mg/90 mg/20 mg per 5 g vaginal gel.
Clinical summary
Citric acid, Lactic acid, l- and Potassium bitartrate is a fixed-dose combination of an anti-coagulant and a calculi dissolution agent. It is available as vaginal gel. MedsAcross supplies Citric acid, Lactic acid, l- and Potassium bitartrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Citric acid, Lactic acid, l- and Potassium bitartrateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Phexx prescribing information (Evofem) · U.S. National Library of Medicine, DailyMed
Need Phexx 50 mg/90 mg/20 mg per 5 g vaginal gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.